Investigational Drug Information for N,N-Dimethyltryptamine
✉ Email this page to a colleague
What is the development status for investigational drug N,N-Dimethyltryptamine?
N,N-Dimethyltryptamine is an investigational drug.
There have been 11 clinical trials for N,N-Dimethyltryptamine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2007.
The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Anxiety Disorders. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and Joshua Woolley, MD/PhD.
Summary for N,N-Dimethyltryptamine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 257 |
| WIPO Patent Applications | 184 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2007-04-01) |
| Vendors | 29 |
Recent Clinical Trials for N,N-Dimethyltryptamine
| Title | Sponsor | Phase |
|---|---|---|
| Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over Study | University Hospital, Basel, Switzerland | Phase 1 |
| Psilocybin Therapy for Chronic Low Back Pain | Joshua Woolley, MD/PhD | Phase 1/Phase 2 |
| Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought | Johns Hopkins University | Phase 1/Phase 2 |
Clinical Trial Summary for N,N-Dimethyltryptamine
Top disease conditions for N,N-Dimethyltryptamine
Top clinical trial sponsors for N,N-Dimethyltryptamine
US Patents for N,N-Dimethyltryptamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
